Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Buckner

Showing results (181-190 of 255) with videos related to

Pageof 26
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 29, 1999
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404M D Prados, C Scott, H Sandler, et al.
Journal of Neuro-Oncology|December 11, 2008
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group resultsMarta Santisteban, Jan C Buckner, Joel M Reid, et al.
Journal of Neuro-Oncology|January 1, 1995
Phase II study of amonafide in patients with recurrent gliomaR Levitt, J C Buckner, T L Cascino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802Edward G Shaw, Meihua Wang, Stephen W Coons, et al.
Journal of Neurosurgery|March 1, 1995
Phase II evaluation of recombinant interferon alpha and BCNU in recurrent gliomaJ C Buckner, L D Brown, J W Kugler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade gliomaR P Dinapoli, L D Brown, R M Arusell, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404Michael D Prados, Wendy Seiferheld, Howard M Sandler, et al.
Neuro-Oncology Advances|August 15, 2022
Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastomaIan F Parney, S Keith Anderson, Michael P Gustafson, et al.
Cancer Research|October 19, 2006
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendrogliomaRobert B Jenkins, Hilary Blair, Karla V Ballman, et al.
Neurosurgery|September 8, 2005
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survivalPaul D Brown, Matthew J Maurer, Teresa A Rummans, et al.
Pageof 26

Showing results (181-190 of 255) with videos related to

Sort By:
Pageof 26
International Journal of Radiation Oncology, Biology, Physics|December 29, 1999
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404M D Prados, C Scott, H Sandler, et al.
Journal of Neuro-Oncology|December 11, 2008
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group resultsMarta Santisteban, Jan C Buckner, Joel M Reid, et al.
Journal of Neuro-Oncology|January 1, 1995
Phase II study of amonafide in patients with recurrent gliomaR Levitt, J C Buckner, T L Cascino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802Edward G Shaw, Meihua Wang, Stephen W Coons, et al.
Journal of Neurosurgery|March 1, 1995
Phase II evaluation of recombinant interferon alpha and BCNU in recurrent gliomaJ C Buckner, L D Brown, J W Kugler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade gliomaR P Dinapoli, L D Brown, R M Arusell, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404Michael D Prados, Wendy Seiferheld, Howard M Sandler, et al.
Neuro-Oncology Advances|August 15, 2022
Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastomaIan F Parney, S Keith Anderson, Michael P Gustafson, et al.
Cancer Research|October 19, 2006
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendrogliomaRobert B Jenkins, Hilary Blair, Karla V Ballman, et al.
Neurosurgery|September 8, 2005
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survivalPaul D Brown, Matthew J Maurer, Teresa A Rummans, et al.
Pageof 26